MicroRNA-125b Potentiates Macrophage Activation

被引:275
作者
Chaudhuri, Aadel A. [1 ]
So, Alex Yick-Lun [1 ]
Sinha, Nikita [1 ]
Gibson, William S. J. [1 ]
Taganov, Konstantin D. [2 ]
O'Connell, Ryan M. [3 ]
Baltimore, David [1 ]
机构
[1] CALTECH, Dept Biol, Div Biol, Pasadena, CA 91125 USA
[2] Regulus Therapeut, San Diego, CA 92121 USA
[3] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
HEMATOPOIETIC STEM-CELLS; SURVIVAL ADVANTAGE; IN-VIVO; EXPRESSION; MIR-125B; DIFFERENTIATION; DEREGULATION; INHIBITION; LEUKEMIA; CANCER;
D O I
10.4049/jimmunol.1102001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MicroRNA (miR)-125b expression is modulated in macrophages in response to stimulatory cues. In this study, we report a functional role of miR-125b in macrophages. We found that miR-125b is enriched in macrophages compared with lymphoid cells and whole immune tissues. Enforced expression of miR-125b drives macrophages to adapt an activated morphology that is accompanied by increased costimulatory factor expression and elevated responsiveness to IFN-gamma, whereas anti-miR-125b treatment decreases CD80 surface expression. To determine whether these alterations in cell signaling, gene expression, and morphology have functional consequences, we examined the ability of macrophages with enhanced miR-125b expression to present Ags and found that they better stimulate T cell activation than control macrophages. Further indicating increased function, these macrophages were more effective at killing EL4 tumor cells in vitro and in vivo. Moreover, miR-125b repressed IFN regulatory factor 4 (IRF4), and IRF4 knockdown in macrophages mimicked the miR-125b overexpression phenotype. In summary, our evidence suggests that miR-125b is at least partly responsible for generating the activated nature of macrophages, at least partially by reducing IRF4 levels, and potentiates the functional role of macrophages in inducing immune responses. The Journal of Immunology, 2011, 187: 5062-5068.
引用
收藏
页码:5062 / 5068
页数:7
相关论文
共 35 条
  • [1] The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs
    Androulidaki, Ariadne
    Iliopoulos, Dimitrios
    Arranz, Alicia
    Doxaki, Christina
    Schworer, Steffen
    Zacharioudaki, Vassiliki
    Margioris, Andrew N.
    Tsichlis, Philip N.
    Tsatsanis, Christos
    [J]. IMMUNITY, 2009, 31 (02) : 220 - 231
  • [2] Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
    Bousquet, Marina
    Quelen, Cathy
    Rosati, Roberto
    Mansat-De Mas, Ronique
    La Starza, Roberta
    Bastard, Christian
    Lippert, Eric
    Talmant, Pascaline
    Lafage-Pochitaloff, Marina
    Leroux, Dominique
    Gervais, Carine
    Viguie, Franck
    Lai, Jean-Luc
    Terre, Christine
    Beverlo, Berna
    Sambani, Costantina
    Hagemeijer, Anne
    Marynen, Peter
    Delsol, Georges
    Dastugue, Nicole
    Mecucci, Cristina
    Brousset, Pierre
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (11) : 2499 - 2506
  • [3] MicroRNA miR-125b causes leukemia
    Bousquet, Marina
    Harris, Marian H.
    Zhou, Beiyan
    Lodish, Harvey F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (50) : 21558 - 21563
  • [4] Potent inhibition of microRNA in vivo without degradation
    Davis, Scott
    Propp, Stephanie
    Freier, Susan M.
    Jones, Laura E.
    Serra, Martin J.
    Kinberger, Garth
    Bhat, Balkrishen
    Swayze, Eric E.
    Bennett, C. Frank
    Esau, Christine
    [J]. NUCLEIC ACIDS RESEARCH, 2009, 37 (01) : 70 - 77
  • [5] Most mammalian mRNAs are conserved targets of microRNAs
    Friedman, Robin C.
    Farh, Kyle Kai-How
    Burge, Christopher B.
    Bartel, David P.
    [J]. GENOME RESEARCH, 2009, 19 (01) : 92 - 105
  • [6] Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
    Gefen, N.
    Binder, V.
    Zaliova, M.
    Linka, Y.
    Morrow, M.
    Novosel, A.
    Edry, L.
    Hertzberg, L.
    Shomron, N.
    Williams, O.
    Trka, J.
    Borkhardt, A.
    Izraeli, S.
    [J]. LEUKEMIA, 2010, 24 (01) : 89 - 96
  • [7] Downregulation of miR-125b in metastatic cutaneous malignant melanoma
    Glud, Martin
    Rossing, Maria
    Hother, Christoffer
    Holst, Line
    Hastrup, Nina
    Nielsen, Finn C.
    Gniadecki, Robert
    Drzewiecki, Krzysztof T.
    [J]. MELANOMA RESEARCH, 2010, 20 (06) : 479 - 484
  • [8] MicroRNA targeting specificity in mammals: Determinants beyond seed pairing
    Grimson, Andrew
    Farh, Kyle Kai-How
    Johnston, Wendy K.
    Garrett-Engele, Philip
    Lim, Lee P.
    Bartel, David P.
    [J]. MOLECULAR CELL, 2007, 27 (01) : 91 - 105
  • [9] MiR-125b targets BCL3 and suppresses ovarian cancer proliferation
    Guan, Yi
    Yao, Hailan
    Zheng, Zhihong
    Qiu, Guangrong
    Sun, Kailai
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2274 - 2283
  • [10] MicroRNA 125b inhibition of B cell differentiation in germinal centers
    Gururajan, Murali
    Haga, Christopher L.
    Das, Sabyasachi
    Leu, Chuen-Miin
    Hodson, Daniel
    Josson, Sajni
    Turner, Martin
    Cooper, Max D.
    [J]. INTERNATIONAL IMMUNOLOGY, 2010, 22 (07) : 583 - 592